VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 174 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,053 | -79.9% | 60,892 | -69.3% | 0.00% | -100.0% |
| Q2 2023 | $1,306,949 | +18.3% | 198,323 | +21.9% | 0.00% | 0.0% |
| Q1 2023 | $1,105,080 | -7.6% | 162,751 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $1,196,523 | -24.9% | 161,911 | +0.3% | 0.00% | 0.0% |
| Q3 2022 | $1,594,000 | +81.1% | 161,392 | +100.2% | 0.00% | – |
| Q2 2022 | $880,000 | +145.1% | 80,615 | +153.9% | 0.00% | – |
| Q1 2022 | $359,000 | -27.9% | 31,751 | 0.0% | 0.00% | – |
| Q4 2021 | $498,000 | -8.8% | 31,751 | -0.5% | 0.00% | – |
| Q3 2021 | $546,000 | – | 31,897 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |